However, after the treatment of rh-endostatin, MDSCs frequency in the spleen of tumor-bearing mice was comparable with its control (7.65±1.65% vs 7.82±1.51%, p = 0.394, Fig. 7A and B). The gene discussed is COL18A1; the disease is neoplasm.